journal article·2024-11

A Functionalized Scaffold Facilitates Neurites Extension for Spinal Cord Injury Therapy

Tianchen Huang, Jiafu Mu, Jiahe Wu, Jian Cao, Xunqi Zhang, Jing Guo, Manning Zhu, Teng Ma, Xinchi Jiang, Shiqing Feng, Jianqing Gao

Small· Volume 20· Issue 45
Publisher page

Abstract

Abstract Scaffolds have garnered considerable attention for enhancing neural repairment for spinal cord injury (SCI) treatment. Both microstructural features and biochemical modifications play pivotal roles in influencing the interaction of cells with the scaffold, thereby affecting tissue regeneration. Here, a scaffold is designed with spiral structure and gradient peptide modification (GS) specifically for SCI treatment. The spiral structure provides crucial support and space, while the gradient peptide isoleucine‐lysine‐valine‐alanine‐valine (IKVAV) modification imparts directional guidance for neuronal and axonal extension. GS scaffold shows a significant nerve extension induction effect through its interlayer gap and gradient peptide density to dorsal root ganglia in vitro, while in vivo studies reveal its substantial promotion for functional recovery and neural repair. Additionally, the GS scaffold displays impressive drug‐loading capacity, mesenchymal stem cell‐derived exosomes can be efficiently loaded into the GS scaffold and delivered to the injury site, thereby synergistically promoting SCI repair. Overall, the GS scaffold can serve as a versatile platform and present a promising multifunctional approach for SCI treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nerve injury and regeneration · Spinal Cord Injury Research · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang 310058 P. R. China

Hangzhou Institute of Innovative Medicine College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang 310058 P. R. China

Department of Clinical Pharmacology Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province Affiliated Hangzhou First People's Hospital Westlake University School of Medicine Hangzhou Zhejiang 310006 P. R. China

Department of Orthopaedics Tianjin Medical University General Hospital Tianjin Key Laboratory of Spine and Spinal Cord Tianjin 300052 P. R. China

The Second Hospital of Shandong University Cheeloo College of Medicine Shandong University Jinan 250012 P. R. China

Jinhua Institute of Zhejiang University Jinhua Zhejiang 321002 P. R. China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China Stem Cell and Translational Research

References (47)

Show source-provided references
1. 10.1038/nrdp.2017.1810.1038/nrdp.2017.18 ↗
2. 10.1038/s41565-023-01416-010.1038/s41565-023-01416-0 ↗
3. 10.1021/acsnano.9b0759810.1021/acsnano.9b07598 ↗
4. 10.1038/s41467-019-11707-710.1038/s41467-019-11707-7 ↗
5. 10.3389/fbioe.2023.111188210.3389/fbioe.2023.1111882 ↗
6. 10.1021/acsami.3c0618910.1021/acsami.3c06189 ↗
7. 10.1016/j.cej.2023.14219210.1016/j.cej.2023.142192 ↗
8. 10.1021/acs.nanolett.0c0092910.1021/acs.nanolett.0c00929 ↗
9. 10.1002/advs.20230163910.1002/advs.202301639 ↗
10. 10.1016/j.bioactmat.2021.11.03210.1016/j.bioactmat.2021.11.032 ↗
11. 10.1126/science.abh360210.1126/science.abh3602 ↗
12. 10.1021/acsnano.0c0357010.1021/acsnano.0c03570 ↗
13. 10.1016/j.biomaterials.2010.03.08110.1016/j.biomaterials.2010.03.081 ↗
14. 10.1007/s10439-007-9348-010.1007/s10439-007-9348-0 ↗
15. 10.1002/adhm.20190091310.1002/adhm.201900913 ↗
16. 10.1021/acsami.9b0851010.1021/acsami.9b08510 ↗
17. 10.1016/j.biomaterials.2020.11997810.1016/j.biomaterials.2020.119978 ↗
18. 10.7150/thno.3627210.7150/thno.36272 ↗
19. 10.1016/j.bioactmat.2023.01.02310.1016/j.bioactmat.2023.01.023 ↗
20. 10.1002/adhm.20200189610.1002/adhm.202001896 ↗
21. 10.1016/j.biomaterials.2015.03.05210.1016/j.biomaterials.2015.03.052 ↗
22. 10.1016/j.biomaterials.2014.04.02710.1016/j.biomaterials.2014.04.027 ↗
23. 10.1016/j.actbio.2018.04.00510.1016/j.actbio.2018.04.005 ↗
24. 10.1016/j.bioactmat.2021.04.01910.1016/j.bioactmat.2021.04.019 ↗
25. 10.1186/1742-2094-8-11010.1186/1742-2094-8-110 ↗
26. 10.1186/s12974-020-1726-710.1186/s12974-020-1726-7 ↗
27. 10.1002/adhm.20210008910.1002/adhm.202100089 ↗
28. 10.1016/j.cell.2021.10.02910.1016/j.cell.2021.10.029 ↗
29. 10.1016/0014-5793(95)00475-O10.1016/0014-5793(95)00475-O ↗
30. 10.1002/adhm.20220164610.1002/adhm.202201646 ↗
31. 10.1039/D0BM01454K10.1039/D0BM01454K ↗
32. 10.1002/adfm.20140453110.1002/adfm.201404531 ↗
33. 10.1016/j.bioactmat.2021.06.02710.1016/j.bioactmat.2021.06.027 ↗
34. 10.1126/sciadv.adg023410.1126/sciadv.adg0234 ↗
35. 10.1016/j.actbio.2018.12.01810.1016/j.actbio.2018.12.018 ↗
36. 10.1021/acsami.2c1000610.1021/acsami.2c10006 ↗
37. 10.1021/acsami.8b1551710.1021/acsami.8b15517 ↗
38. Lin Y. T. · J. Visualized Exp. · 2018 · 140
39. 10.1016/j.jconrel.2019.02.03810.1016/j.jconrel.2019.02.038 ↗
40. 10.1039/D1BM01722E10.1039/D1BM01722E ↗
41. 10.1021/acsnano.2c0289810.1021/acsnano.2c02898 ↗
42. 10.1021/acsnano.9b0189210.1021/acsnano.9b01892 ↗
43. 10.1016/j.jconrel.2023.09.02610.1016/j.jconrel.2023.09.026 ↗
44. 10.3390/ijms2120753310.3390/ijms21207533 ↗
45. 10.1038/s41392-023-01477-610.1038/s41392-023-01477-6 ↗
46. 10.1002/adma.20230489610.1002/adma.202304896 ↗
47. 10.1038/s41467-023-39745-210.1038/s41467-023-39745-2 ↗